Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srivalli N Telikepalli

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Scientific Reports|November 22, 2023
Morphologically-Directed Raman Spectroscopy as an Analytical Method for Subvisible Particle Characterization in Therapeutic Protein Product QualityMinkyung Kim, Youlong Ma, Charudharshini Srinivasan, et al.
Journal of Pharmaceutical Sciences|January 24, 2014
Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditionsSrivalli N Telikepalli, Ozan S Kumru, Cavan Kalonia, et al.
Scientific Reports|November 25, 2025
Root cause analysis investigation of visible particulates in therapeutic protein drug products using morphologically directed Raman spectroscopyIsabella F de Luna, Srivalli N Telikepalli, Michael Carrier, et al.
Protein Science : a Publication of the Protein Society|July 22, 2014
Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometrySubhashchandra Naik, Ozan S Kumru, Melissa Cullom, et al.
AAPS Pharmscitech|December 16, 2022
An Interlaboratory Study to Identify Potential Visible Protein-Like Particle StandardsSrivalli N Telikepalli, Michael J Carrier, Dean C Ripple, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Scientific Reports|November 22, 2023
Morphologically-Directed Raman Spectroscopy as an Analytical Method for Subvisible Particle Characterization in Therapeutic Protein Product QualityMinkyung Kim, Youlong Ma, Charudharshini Srinivasan, et al.
Journal of Pharmaceutical Sciences|January 24, 2014
Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditionsSrivalli N Telikepalli, Ozan S Kumru, Cavan Kalonia, et al.
Scientific Reports|November 25, 2025
Root cause analysis investigation of visible particulates in therapeutic protein drug products using morphologically directed Raman spectroscopyIsabella F de Luna, Srivalli N Telikepalli, Michael Carrier, et al.
Protein Science : a Publication of the Protein Society|July 22, 2014
Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometrySubhashchandra Naik, Ozan S Kumru, Melissa Cullom, et al.
AAPS Pharmscitech|December 16, 2022
An Interlaboratory Study to Identify Potential Visible Protein-Like Particle StandardsSrivalli N Telikepalli, Michael J Carrier, Dean C Ripple, et al.
Pageof 1